PFENYSEPharmaceutical PreparationsFiscal year ends December 31
PFIZER INC
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026
$29.44−0.14 (-0.47%)
Close on Oct 19, 2026
- Market cap
- $167.78B
- P/E (TTM)
- 38.7
- Dividend yield
- 5.84%
Debt
Borrowings on the balance sheet, Jun 28, 2026
Total debt
$63.19B
$2.70B due within a year
Net debt
$62.22B
After $976.00M of cash
Implied interest rate
4.14%
FY2025 interest ÷ average debt
Interest coverage
–
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Bond issues
Individual notes and bonds outstanding
Bond-level data is not connected yet
Coupon, maturity and amount of each note will come from the debt footnote in Pfizer's annual report. Trading prices and yields need FINRA TRACE data.